Serum immune modulators during the first cycle of anti‐PD‐1 antibody therapy in non‐small cell lung cancer: Perforin as a biomarker

by Takayo Ota, Tomoya Fukui, Yoshiro Nakahara, Takayuki Takeda, Junji Uchino, Takako Mouri, Keita Kudo, Saki Nakajima, Tomohiro Suzumura, Masahiro Fukuoka
Published 2020-11-01

C609T Polymorphism of NADPH Quinone Oxidoreductase 1 Correlates Clinical Hematological Toxicities in Lung Cancer Patients Treated with Amrubicin

by Misato Nagata, Tatsuo Kimura, Tomohiro Suzumura, Yukimi Kira, Toshiyuki Nakai, Kanako Umekawa, Hidenori Tanaka, Kuniomi Matsuura, Shigeki Mitsuoka, Naruo Yoshimura, Takako Oka, Shinzoh Kudoh, Kazuto Hirata
Published 2013-02-01

C609T polymorphism of NADPH Quinone Oxidoreductase 1 Correlates Clinical Hematological Toxicities in Lung Cancer Patients Treated with Amrubicin

by Misato Nagata, Tatsuo Kimura, Tomohiro Suzumura, Yukimi Kira, Toshiyuki Nakai, Kanako Umekawa, Hidenori Tanaka, Kuniomi Matsuura, Shigeki Mitsuoka, Naruo Yoshimura, Takako Oka, Shinzoh Kudoh, Kazuto Hirata
Published 2013-01-01

Mutational landscape of multiple primary lung cancers and its correlation with non-intrinsic risk factors

by Motohiro Izumi, Jun Oyanagi, Kenji Sawa, Mitsuru Fukui, Koichi Ogawa, Yoshiya Matsumoto, Yoko Tani, Tomohiro Suzumura, Tetsuya Watanabe, Hiroyasu Kaneda, Shigeki Mitsuoka, Kazuhisa Asai, Masahiko Ohsawa, Nobuyuki Yamamoto, Yasuhiro Koh, Tomoya Kawaguchi
Published 2021-03-01

Tumor microenvironment disparity in multiple primary lung cancers: Impact of non-intrinsic factors, histological subtypes, and genetic aberrations

by Motohiro Izumi, Kenji Sawa, Jun Oyanagi, Ikue Noura, Mitsuru Fukui, Koichi Ogawa, Yoshiya Matsumoto, Yoko Tani, Tomohiro Suzumura, Tetsuya Watanabe, Hiroyasu Kaneda, Shigeki Mitsuoka, Kazuhisa Asai, Noritoshi Nishiyama, Masahiko Ohsawa, Nobuyuki Yamamoto, Yasuhiro Koh, Tomoya Kawaguchi
Published 2021-07-01